Skip to main content

Providing Fuel for Startups Since 2008

Who We Are
NTAN is a Texas non-profit corporation that seeks out quality deals for angel investor consideration.

We are a part of a statewide network of angel groups that cooperate on deals across Texas. Our members identify and screen applicant companies, providing capital to selected opportunities to assist in their growth. Exceptional entrepreneurs from any industry are encouraged to apply.

We offer Individual, Institutional, and Supporting membership options. We also welcome Corporate sponsorship and participation.

NTAN acts solely as a facilitator, providing members with a forum in which to analyze, invest, assist, and monitor investment opportunities. NTAN does not provide investment advice.

img_5393.jpeg

Prior to Applying
Investment Criteria

NTAN accepts applications from entrepreneurial companies seeking funding that are domiciled in the U.S.

NTAN typically invests in companies within the SaaS, Fintech, B2B & B2C technology, Web3, health care and services industries. The following categories do not meet our investment criteria: Venture Funds; Ventures with a large real estate component; TV or Radio programs; Film, Theatre, or Art productions; Non-profit organizations; Organizations domiciled outside of the U.S.

We do not fund companies using the 506(c) exemption or Reg CF (Crowdfunding) or where our investments are subject to a broker/dealer fee. Companies that previously used the 506(c) exemption or Reg CF (Crowdfunding) must agree to self-certification of accredited status by our investors.

NTAN looks for these characteristics:

  • A capable management team with domain expertise
  • A scalable business model
  • An addressable market of at least $500 million
  • Limited capital expenditure requirements
  • Opportunities that can be accelerated with support from our investors
  • A product or service in beta (versus alpha) stage of development that has been created with input from clients or potential clients
  • “Proof of concept” revenue or significant pilots, except for health care bio/pharma, diagnostics and devices companies
  • A plausible exit strategy within 5-8 years
  • Valuation at first funding typically below $10 million
  • Typically seeking first-round of funding of $200,000-$1,500,000
pexels-energepiccom-110473.jpg
Our team
Learn more about our NTAN Board Members

NTAN associates
We are proud to be a Member of

Let's talk
We would love to hear from you!